Origene Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Debt - PPP

  • Latest Deal Amount
  • $1.02M

Origene General Information

Description

Provider of gene-centric research tools for the pharmaceutical and biotechnology sectors designed to develop genome-wide knockout cells from commonly used laboratory cell lines. The company's research tools develop and sell cDNA clone collection, a searchable gene bank of human full-length TrueClone cDNA collection and TrueORF cDNA clones, thereby enabling pharmaceutical, biotechnology and academic research companies to validate antibodies and develop new drugs.

Contact Information

Website
www.origene.com
Formerly Known As
Origen Technologies
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 9620 Medical Center Drive
  • Suite 200
  • Rockville, MD 20850
  • United States
+1 (301)
Primary Industry
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • 9620 Medical Center Drive
  • Suite 200
  • Rockville, MD 20850
  • United States
+1 (301)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Origene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Debt - PPP 06-May-2020 $1.02M Completed Generating Revenue
10. Merger/Acquisition 13-Feb-2017 Completed Generating Revenue
9. Secondary Transaction - Private 01-Dec-2016 Completed Generating Revenue
8. Later Stage VC 09-Jun-2015 Completed Generating Revenue
7. Later Stage VC 10-Mar-2014 Completed Generating Revenue
6. Later Stage VC (Series C) 19-Mar-2013 Completed Generating Revenue
5. Later Stage VC (Series B) 18-Mar-2010 Completed Product Development
4. Secondary Transaction - Private 01-May-2009 Completed Startup
3. Grant 01-Jan-2005 $391K Completed Startup
2. Grant 01-Jan-2000 $314K Completed Startup
To view Origene’s complete valuation and funding history, request access »

Origene Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of gene-centric research tools for the pharmaceutical and biotechnology sectors designed to develop genome-wide
Discovery Tools (Healthcare)
Rockville, MD

Saclay, France
 

Poway, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Origene Competitors (16)

One of Origene’s 16 competitors is CIS Bio International, a Formerly PE-Backed company based in Saclay, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CIS Bio International Formerly PE-Backed Saclay, France
ProSci (Biotechnology) Private Equity-Backed Poway, CA
Molecular Cloning Laboratories Corporation South San Francisco, CA
Abcam Corporate Backed or Acquired Cambridge, United Kingdom
Twist Bioscience Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 16 competitors. Get the full list »

Origene Patents

Origene Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2010298238-A1 Protein arrays and uses thereof Inactive 25-Sep-2009
CA-2774615-A1 Protein arrays and uses thereof Inactive 25-Sep-2009
EP-2480892-A1 Protein arrays and uses thereof Inactive 25-Sep-2009
US-20120231969-A1 Protein arrays and uses thereof Inactive 25-Sep-2009
WO-2011038138-A1 Protein arrays and uses thereof Inactive 25-Sep-2009 G01N33/68
To view Origene’s complete patent history, request access »

Origene Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Accel Venture Capital Minority
BroadOak Capital Partners Growth/Expansion Minority
Cathay Capital PE/Buyout Minority
Emerging Technology Partners (Venture Capital) Venture Capital Minority
IDG Capital Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Origene Acquisitions (7)

Origene’s most recent deal was a Merger/Acquisition with Acris Antibodies. The deal was made on 28-Oct-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Acris Antibodies 28-Oct-2015 Merger/Acquisition Distributors (Healthcare)
BioCheck 26-Feb-2014 Merger/Acquisition Diagnostic Equipment
Strategic Diagnostics (Life-Science Assets) 15-Jun-2013 Merger/Acquisition Buildings and Property
SDIX 08-Apr-2013 Merger/Acquisition Biotechnology
Beijing Zhongshan Golden Bridge Biotechnology 12-Mar-2012 Merger/Acquisition Other Devices and Supplies
You’re viewing 5 of 7 acquisitions. Get the full list »

Origene Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
BioCheck Pleasant Hill, CA 1997
SDIX Newark, DE 1990

Origene FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process